These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25478082)

  • 1. Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients.
    Moritz S; Peters MJ; Karow A; Deljkovic A; Tonn P; Naber D
    Ment Illn; 2009 Oct; 1(1):e2. PubMed ID: 25478082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis.
    Moritz S; Favrod J; Andreou C; Morrison AP; Bohn F; Veckenstedt R; Tonn P; Karow A
    Schizophr Bull; 2013 Jul; 39(4):917-22. PubMed ID: 22337789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis.
    Wade M; Tai S; Awenat Y; Haddock G
    Clin Psychol Rev; 2017 Feb; 51():75-95. PubMed ID: 27838461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonadherence to antipsychotics: the role of positive attitudes towards positive symptoms.
    Moritz S; Hünsche A; Lincoln TM
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1745-52. PubMed ID: 25444234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight.
    Garavan J; Browne S; Gervin M; Lane A; Larkin C; O'Callaghan E
    Compr Psychiatry; 1998; 39(4):215-9. PubMed ID: 9675506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment.
    Löffler W; Kilian R; Toumi M; Angermeyer MC
    Pharmacopsychiatry; 2003 May; 36(3):105-12. PubMed ID: 12806568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are schizophrenic patients being told their diagnosis today in France?].
    Villani M; Kovess-Masféty V
    Encephale; 2017 Apr; 43(2):160-169. PubMed ID: 27372353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
    Naber D
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():133-8. PubMed ID: 8866775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boredom, dopamine, and the thrill of psychosis: psychiatry in a new key.
    Branković S
    Psychiatr Danub; 2015 Jun; 27(2):126-37. PubMed ID: 26057307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postdischarge medication compliance of inpatients converted from an oral to a depot neuroleptic regimen.
    Weiden P; Rapkin B; Zygmunt A; Mott T; Goldman D; Frances A
    Psychiatr Serv; 1995 Oct; 46(10):1049-54. PubMed ID: 8829787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.
    Kampman O; Lehtinen K; Lassila V; Leinonen E; Poutanen O; Koivisto A
    Schizophr Res; 2000 Oct; 45(3):223-34. PubMed ID: 11042440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rating of medication influences (ROMI) scale in schizophrenia.
    Weiden P; Rapkin B; Mott T; Zygmunt A; Goldman D; Horvitz-Lennon M; Frances A
    Schizophr Bull; 1994; 20(2):297-310. PubMed ID: 7916162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative symptoms of schizophrenia and compliance with medication.
    Tattan TM; Creed FH
    Schizophr Bull; 2001; 27(1):149-55. PubMed ID: 11215543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial compliance with antipsychotics and its impact on patient outcomes.
    Narasimhan M; Un Pae C; Masand N; Masand P
    Int J Psychiatry Clin Pract; 2007; 11(2):102-11. PubMed ID: 24937555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subjective experiences of people who regularly receive depot neuroleptic medication in the community.
    Phillips L; McCann E
    J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.